Production (Stage)
Acumen Pharmaceuticals, Inc.
ABOS
$1.02
-$0.01-0.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 149.15M | 171.56M | 200.34M | 260.47M | 252.51M |
| Total Receivables | 707.00K | 628.00K | 319.00K | 106.00K | 189.00K |
| Inventory | -- | 159.00K | 143.00K | 121.00K | 124.00K |
| Prepaid Expenses | 481.00K | 858.00K | 1.01M | 95.00K | 411.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.61M | 5.10M | 5.82M | 6.12M | 2.60M |
| Total Current Assets | 154.95M | 178.31M | 207.63M | 266.92M | 255.83M |
|
|
|||||
| Total Current Assets | 154.95M | 178.31M | 207.63M | 266.92M | 255.83M |
| Net Property, Plant & Equipment | 373.00K | 339.00K | 385.00K | 430.00K | 470.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 56.00K | -- | -- | 184.00K | 186.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 307.00K | 379.00K | 406.00K | 476.00K | 372.00K |
| Total Assets | 204.48M | 238.99M | 266.98M | 288.91M | 300.97M |
|
|
|||||
| Total Accounts Payable | 1.06M | 5.65M | 2.34M | 4.21M | 3.08M |
| Total Accrued Expenses | 17.70M | 21.60M | 17.24M | 10.88M | 4.79M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 138.00K | 133.00K | 129.00K | 125.00K | 121.00K |
| Total Finance Division Other Current Liabilities | 418.00K | 230.00K | 201.00K | 149.00K | 481.00K |
| Total Other Current Liabilities | 418.00K | 230.00K | 201.00K | 149.00K | 481.00K |
| Total Current Liabilities | 19.32M | 27.61M | 19.91M | 15.37M | 8.47M |
|
|
|||||
| Total Current Liabilities | 19.32M | 27.61M | 19.91M | 15.37M | 8.47M |
| Long-Term Debt | 29.53M | 29.42M | 29.67M | 29.38M | 30.21M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 114.00K | 150.00K | 185.00K | 219.00K | 252.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 48.96M | 57.18M | 49.77M | 44.97M | 38.93M |
|
|
|||||
| Common Stock & APIC | 509.43M | 506.99M | 504.66M | 502.32M | 499.85M |
| Retained Earnings | -353.92M | -325.13M | -287.97M | -258.21M | -237.67M |
| Treasury Stock & Other | 15.00K | -48.00K | 518.00K | -164.00K | -144.00K |
| Total Common Equity | 155.52M | 181.82M | 217.20M | 243.95M | 262.03M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 155.52M | 181.82M | 217.20M | 243.95M | 262.03M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 155.52M | 181.82M | 217.20M | 243.95M | 262.03M |
|
|
|||||